BAM
TAK icon

Blueshift Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Blueshift Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,523
Closed -$162K – 837
2022
Q2 		$162K Sell
11,523
-1,529
-12% -$21.8K 0.03% 596
2022
Q1 		$187K Buy
+13,052
New +$192K 0.02% 742
2021
Q1 		– Sell
-23,680
Closed -$431K – 1067
2020
Q4 		$431K Sell
23,680
-25,401
-52% -$446K 0.05% 443
2020
Q3 		$876K Buy
+49,081
New +$894K 0.12% 233
2020
Q1 		– Sell
-71,217
Closed -$1.41M – 642
2019
Q4 		$1.41M Buy
+71,217
New +$1.36M 0.16% 195
2019
Q3 		– Sell
-33,232
Closed -$588K – 951
2019
Q2 		$588K Sell
33,232
-5,759
-15% -$105K 0.08% 369
2019
Q1 		$794K Buy
+38,991
New +$785K 0.11% 295

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return